BRTX
BioRestorative Therapies, Inc.Company with tickers: BRTX
CIK
1505497
CUSIP
090655606
Shares Outstanding
25,478,170
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $23,170 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | $15,785 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $3,401,518 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $1,926,311 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-3,385,733 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-2,154,405 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.12 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.12 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |